Review
Hypertriglyceridemia: its etiology, effects and treatment
George Yuan, Khalid Z. Al-Shali and Robert A. Hegele
CMAJ April 10, 2007 176 (8) 1113-1120; DOI: https://doi.org/10.1503/cmaj.060963
George Yuan
Khalid Z. Al-Shali
In this issue
CMAJ
Vol. 176, Issue 8
10 Apr 2007
Article tools
Respond to this article
Hypertriglyceridemia: its etiology, effects and treatment
George Yuan, Khalid Z. Al-Shali, Robert A. Hegele
CMAJ Apr 2007, 176 (8) 1113-1120; DOI: 10.1503/cmaj.060963
Jump to section
Related Articles
Cited By...
- Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestry
- Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study
- Body condition score and triglyceride concentrations and their associations with other markers of energy homeostasis in healthy, non-obese dogs
- Pre-symptomatic reduction of individuality in the AppNL-F knock-in model of Alzheimers disease
- Severe acquired hypertriglyceridemia following COVID-19
- Acute pancreatitis secondary to hypertriglyceridemia
- Coronary artery disease risk and lipidomic profiles are similar in familial and population-ascertained hyperlipidemias
- Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition
- Low fasting serum insulin and dementia in nondiabetic women followed for 34 years
- Approach to Hypertriglyceridemia in the Pediatric Population
- Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol
- Case 2: Diffuse Papulopustular Rash in an 11-week-old Boy
- Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia
- A Functional Variant in APOA5/A4/C3/A1 Gene Cluster Contributes to Elevated Triglycerides and Severity of CAD by Interfering With MicroRNA 3201 Binding Efficiency
- Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice
- Fenofibrate-associated nephrotoxicity: A review of current evidence
- Paediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia
- Hypertriglyceridemia-induced acute pancreatitis treated with insulin and heparin
- An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia
- Rapid Reduction of Severely Elevated Serum Triglycerides with Insulin Infusion, Gemfibrozil and Niacin
- Genetic determinants of plasma triglycerides
- Intravenous Injection of Apolipoprotein A-V Reconstituted High-Density Lipoprotein Decreases Hypertriglyceridemia in apoav-/- Mice and Requires Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1
- Hepatic lipase deficiency in a Middle-Eastern-Arabic male
- Apolipoprotein E Polymorphisms and Postprandial Triglyceridemia Before and After Fenofibrate Treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study
- Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus
- Investigation and management of hypertriglyceridaemia
- (-)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-db/db Mice
- Treating hypertriglyceridemia
- Treating hypertriglyceridemia
- Treating hypertriglyceridemia
- Treating hypertriglyceridemia
- Apolipoprotein A-V Genetic Variation and Plasma Lipoprotein Response to Fibrates